Toggle light / dark theme

“One way or another, this technology is coming. These cars are already being tested in cities,” Richard Ezike, the lead author of the study, said in an organization-published press release. “If we do not plan and set out thoughtful policies, driverless cars could exacerbate the challenges we see in transportation today — especially for underserved communities.”

Take the Bus

The researchers argue that cities that introduce autonomous vehicles should also invest in public transit, to make sure that those who have longer commutes and would get stuck in the newly-introduced congestion can still find and make it to their jobs.

Read more

Recently University of Glasgow developed a Graphene based E-Skin for prosthetic limbs. The research started with making a prosthetic arm that could sense even the minutest of pressure for gripping soft objects. It eventually yielded a prosthetic limb that was also self powering.

This was because of the development of Graphene based supercapacitors.

Graphene is now being explored for wearable electronics and health pathes because of its flexibility and ability to pick the smallest of signals.

Read more

This is awesome and WAY deserved.


A NASA facility in Fairmont, West Virginia, will be renamed after native Katherine Johnson, a pioneering mathematician who was depicted in the 2016 film “Hidden Figures” for her critical role in the success of the U.S. reaching space.

The Herbert Henderson Office of Minority Affairs announced the recognition of Johnson on Friday, according to The Register-Herald.

Jill Upson, the executive director of the office, reportedly spearheaded the process to have the facility renamed in 2017.

Phinergy is a leading developer of breakthrough, absolutely zero emission, high energy density systems based on metal air energy technologies, mainly Aluminum-Air and Zinc-Air. Unlike conventional batteries that carry oxygen, these batteries freely breathe oxygen from the ambient air to release the energy contained in metals.

(274361)

Category: Innovation

Read more

Bezos: “I don’t think we’ll live on planets…I think we’ll live in giant O’Neal-style space colonies.”


  • Jeff Bezos, the founder of Amazon, gave a talk to a members-only event at the Yale Club in New York on Tuesday.
  • During the 30-minute lecture, Bezos said his private aerospace company, Blue Origin, would launch its first people into space aboard a New Shepard rocket in 2019.
  • Bezos also questioned the capabilities of a space tourism competitor, Virgin Galactic, and criticized the goal of Elon Musk and SpaceX to settle Mars with humans.
  • Ultimately, Bezos said he wants Blue Origin to enable a space-faring civilization where “a Mark Zuckerberg of space” and “1,000 Mozarts and 1,000 Einsteins” can flourish.
  • Bezos advised the crowd to hold a powerful, personal long-term vision, but to devote “the vast majority of your energy and attention” on shorter-term activities and those ranging up to 2- or 3-year timeframes.

Jeff Bezos may be the richest human on Earth, as the founder of Amazon, but his ultimate dreams reside within a relatively obscure company called Blue Origin.

In fact, as Bezos told the CEO of Business Insider’s parent company in April 2018, he liquidates $1 billion of stock a year to fund his private aerospace outfit.

A study published today in Cell describes a form of “interspecies communication” in which bacteria secrete a specific molecule — nitric oxide — that allows them to communicate with and control their hosts’ DNA, and suggests that the conversation between the two may broadly influence human health.

The researchers out of Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, and Harvard Medical School tracked nitric oxide secreted by gut bacteria inside tiny worms (C. elegans, a common mammalian laboratory model). Nitric oxide secreted by gut bacteria attached to thousands of host proteins, completely changing a worm’s ability to regulate its own gene expression.

The study is the first to show gut bacteria can tap into nitric oxide networks ubiquitous in mammals, including humans. Nitric oxide attaches to human proteins in a carefully regulated manner — a process known as S-nitrosylation — and disruptions are broadly implicated in diseases such as Alzheimer’s, Parkinson’s, asthma, diabetes, heart disease, and cancer.

Read more